Aptagen, LLC
SARS Coronavirus NTPase/Helicase (ES15-1) (ID# 7531)
RNA
SARS Coronavirus NTPase/Helicase
Protein
1.2 nM (reported value)
Binding Buffer (30 mM Trisƒ??HCl (pH 7.5), 150 mM NaCl, 1.5 mM MgCl2 , 2 mM dithiothreitol (DTT) and 1% (w/v) BSA) Termination Buffer (0.2 M EDTA, 0.2 M NaCl, and 20 mM HEPES (pH 7.4)) Buffer A (25 mM Trisƒ??HCl (pH 7.5), and 0.3 mM NaCl)
N/A°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
5'-rGprAprUprAprAprUprAprCprGprAprCprUprCprAprCprUprAprUprAprGprGprGprUprUprCprAprCprUprGprCprAprGprAprCprUprUprGprAprCprGprAprAprGprCprUprUprGprCprAprGprAprAprAprAprGprGprGprGprGprAprAprGprAprAprGprAprGprGprGprUprGprAprUprUprCprAprGprGprCprGprAprGprAprGprAprAprUprGprGprAprUprCprCprAprCprAprUprCprUprAprCprGprAprAprUprUprCp-3'
107
34719.1
1104500
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Jang, K., et al. "Isolation of inhibitory RNA aptamers against severe acute respiratory syndrome (SARS) coronavirus NTPase/Helicase." Biochemical and Biophysical Research Communications, 366(2008): 738-744.
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.